National Vision Holdings (EYE) operates 1,274 value optical retail stores — America's Best Contacts & Eyeglasses, Eyeglass World, and military/Walmart partnerships — serving the low-to-moderate income consumer. The stock is down 30% in 30 days (RSI 22.5, near $14.75 52-week low) after the Q1 2026 10-Q disclosed a Q2 website re-platform traffic disruption. The market read the disclosure as a single-quarter air pocket. The cross-ticker evidence suggests something longer.

What the filing says

Q1 2026 was a clean operating beat: revenue +6.6% YoY to $543.9M, Adj OI margin +210bps to 10.2%, Adj Diluted EPS $0.45 vs $0.34 (+32%), operating cash flow +91% to $61.7M. Caveat: $7M of Adj OI came from unearned revenue timing ($0.07 EPS); stripping it leaves Adj OI still cleanly above prior year.

The market-moving disclosure is in MD&A, verbatim: "In the beginning of the second quarter, we made an important strategic move to re-platform AmericasBest.com... A re-platforming of this scale resets parts of the digital storefront and traffic was disrupted as search and social optimization resets... if remediation measures take longer than anticipated to fully materialize, we could continue to experience impacts to traffic and, as a result, our financial performance."

Management did NOT cut FY2026 guidance ($107-133M Adj OI; $0.85-1.09 Adj EPS; 3-6% Adj SSS) despite the disclosure. Balance sheet is clean: $67.9M cash, 0.7x leverage, $300M revolver undrawn, covenant compliant. A $50M buyback was authorized March 2, 2026; $0 has been deployed (Q1 treasury activity was RSU tax withholding, not open market purchases). SSS has been decelerating for three quarters (7.7% Q3 2025 → 4.5% Q1 2026) on lower traffic, masked by higher ticket and managed care strength.

What the market thinks

At $17.45, EYE trades at 16.3x mid-point FY2026 guidance EPS ($0.97). Sell-side mean target is $29.27 with 73% buy ratings — sell-side has not capitulated. Short interest is 18.1% with ≈7 days to cover.

Solving for the implied bull/bear split (binary at $22 bull / $11 bear): market prices ≈59% bull. Our scenario weighting (BULL 35% to $22, BASE 35% to $16, BEAR 20% to $11, TAIL 10% to $8) implies fair value $16.30 — a ≈7% gap below current. Net bear edge is ≈6-7 percentage points.

Why the gap exists

EYE's exact phrase — "search and social optimization resets" — appears across 8+ companies in our worldview with the same disclosure pattern: XPOF (franchise fitness), HUBS (mar-tech), IAC (digital holdco), CARS (auto classifieds), ANGI (home services), NRDS (consumer finance), TDAY (media-tech), PXED (telehealth). They span sectors that don't share an analyst basket. The common mechanism is the customer acquisition funnel: each of these businesses depends on organic search or social discovery to drive the top of the funnel — an exam booking, a franchise lead, a free trial, a mortgage quote. When Meta's Andromeda model launched (mid-2025) and Google's AI Overviews reached ≈50% of search queries, organic click-through rates fell 27-30% across this cohort. The funnel breaks the same way regardless of what the company sells.

A re-platform compounds this. New URLs lose accumulated SEO authority. Social and search optimization rebuild from a lower baseline. The closest direct retail re-platform analog (GRPN, 2024-2025) took 2+ years from start to "new platform place." The cohort base rate is 2-3 quarter drag with guidance cuts typically appearing by Q2 or Q3 of the disruption window. EYE skews to search-discovered self-pay value consumers with thin first-party data — placing it squarely in the exposed cohort, not the defensive (PTON, ETSY, IAC, SHOP) first-party-flywheel cohort.

Sell-side covers EYE as specialty retail, not as a cohort member of a documented latent factor. The cross-sectional pattern is invisible until you tag it. That's where the gap lives.

Risks

1. Q2 prints in-band. Management's "sequential improvement" claim materializes; SSS lands 3-4% and guidance holds. Stock re-rates to $19-22. This is the 35% BULL scenario.
2. Cohort base rate is low-N. ≈3-5 partial analogs. Pattern-matching across different sector verticals could be constructed rather than predictive.
3. Squeeze dynamics. 18% short interest with 7-day cover ratio; any positive Q2 read triggers reflexive short covering before fundamentals resolve.
4. Form 4 codes unverified. March insider cluster ($2.5M) including CFO acquisition could be code P (open market = LR 2-3 bullish) or code A/F (grant/tax = noise). Has not been confirmed.
5. Margin asymmetry could compound. Q1's +210bps margin expansion came from SG&A discipline (payroll -220bps, advertising -70bps), not volume. If management sustains cost discipline through weak Q2 traffic, EPS could miss less than the SSS print suggests. Inverse risk: same operating leverage amplifies a meaningful SSS decline if cost cuts hit a floor.

Catalysts

• Form 4 verification — pending; ≈15 min EDGAR pull
• WRBY Q2 earnings — early August 2026 (tests share-shift hypothesis)
• EYE Q2 10-Q — mid-August 2026 (primary event; SSS print + guidance action)
• EYE Q3 10-Q — mid-November 2026 (cohort base-rate confirm/deny)
• Buyback 8-K — anytime; deployment would be a defense signal

What would change our mind

Stronger bull: Form 4 codes show P on the $2.5M cluster, OR EYE files an 8-K disclosing material buyback deployment, OR Q2 SSS prints ≥3% with guidance held.

Stronger bear: WRBY Q2 e-commerce growth turns positive (share-shift confirmation), OR 4+ of 8 cohort members issue current-year guidance cuts (validates the base rate), OR Q2 SSS prints <2% with guidance trim.

Framework reassess: An actual regression of EYE against SPY/XRT/IVE/MTUM shows %idio variance >70%, indicating the cohort factor is smaller than estimated and EYE is closer to a pure idio story.

The setup at $17.45 is mid-range. The market has done some of the work; the gap is real but small (≈7%); the asymmetry only becomes interesting at the edges (long below $14, short above $20). The resolution date is mid-August. This is a watchlist memo, not a position memo — the question is what to do when the price moves to a clean entry zone or the cohort thesis prints.

Evidence